These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25528331)

  • 21. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
    ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
    Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
    Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heteronuclear gold(I)-silver(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines.
    Barreiro E; Casas JS; Couce MD; Sánchez A; Sordo J; Vázquez-López EM
    J Inorg Biochem; 2014 Feb; 131():68-75. PubMed ID: 24269769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes.
    Krajcinović BB; Kaluderović GN; Steinborn D; Schmidt H; Wagner C; Zizak Z; Juranić ZD; Trifunović SR; Sabo TJ
    J Inorg Biochem; 2008 Apr; 102(4):892-900. PubMed ID: 18226835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.
    Zmejkovski BB; Kaluderović GN; Gómez-Ruiz S; Zizak Z; Steinborn D; Schmidt H; Paschke R; Juranić ZD; Sabo TJ
    Eur J Med Chem; 2009 Sep; 44(9):3452-8. PubMed ID: 19272676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of some platinum(II/IV) complexes with O,O-n-butyl-and O,O-n-pentyl-ethylenediamine-N,N'-di-3-propanoate and halogeno ligands against HeLa and K562 cell lines and human PBMC.
    Kaluderović GN; Dinović VM; Juranić ZD; Stanojković TP; Sabo TJ
    J Inorg Biochem; 2005 Feb; 99(2):488-96. PubMed ID: 15621281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
    Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
    Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
    Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
    Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
    Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
    Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
    Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)pentanoic acid.
    Vujić JM; Kaluđerović GN; Milovanović M; Zmejkovski BB; Volarević V; Živić D; Đurđeviće P; Arsenijević N; Trifunović SR
    Eur J Med Chem; 2011 Sep; 46(9):4559-65. PubMed ID: 21840630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.
    Casini A; Cinellu MA; Minghetti G; Gabbiani C; Coronnello M; Mini E; Messori L
    J Med Chem; 2006 Sep; 49(18):5524-31. PubMed ID: 16942025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereospecific ligands and their complexes. XXII. Synthesis and antitumor activity of palladium(II) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-(2,2'-di(4-hydroxy-benzyl))-acetic acid.
    Stojković DLj; Jevtić VV; Radić GP; Todorović DV; Petrović M; Zarić M; Nikolić I; Baskić D; Trifunović SR
    J Inorg Biochem; 2015 Feb; 143():111-6. PubMed ID: 25528678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.